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Abstract
Type I interferons (IFN-I) are antiviral cytokines that signal through the ubiquitous IFN-I recep-
tor (IFNAR). Following footpad infection with ectromelia virus (ECTV), a mouse-specific path-
ogen, C57BL/6 (B6) mice survive without disease, while B6 mice broadly deficient in IFNAR
succumb rapidly. We now show that for survival to ECTV, only hematopoietic cells require
IFNAR expression. Survival to ECTV specifically requires IFNAR in both natural killer (NK)
cells and monocytes. However, intrinsic IFNAR signaling is not essential for adaptive immune
cell responses or to directly protect non-hematopoietic cells such as hepatocytes, which are
principal ECTV targets. Mechanistically, IFNAR-deficient NK cells have reduced cytolytic
function, while lack of IFNAR in monocytes dampens IFN-I production and hastens virus dis-
semination. Thus, during a pathogenic viral infection, IFN-I coordinates innate immunity by
stimulating monocytes in a positive feedback loop and by inducing NK cell cytolytic function.
Author summary
Type I interferon (IFN-I) is required for resistance to many viral infections and the IFN-I
receptor IFNAR is ubiquitously expressed in most cells. Melo-Silva et al. show that resis-
tance to mousepox, a highly lethal viral disease of mice, requires IFNAR in Natural Killer
cells to promote optimal maturation and cytotoxicity, and in inflammatory monocytes for
a positive feedback loop necessary to induce optimal IFN-I expression. However, intrinsic
IFNAR is dispensable in adaptive lymphocytes or parenchymal cells indicating that for at
least some viral infections, the critical anti-viral effects of IFN-I are restricted to cells of
the innate immune system and are superfluous in other cell types.
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Introduction
Type I interferons (IFN-I) are a family of highly conserved antiviral cytokines. IFN-I bind to
the IFN-I receptor IFNAR, a heterodimer composed of IFNAR1 and IFNAR2. Binding of
IFN-I to IFNAR induces a signaling cascade that culminates in the upregulation of interferon-
stimulated genes (ISG) [1]. ISGs induce an antiviral state in cells that curtail viral replication
[2]. IFN-I is also thought to activate innate and adaptive immune responses through direct
and indirect IFNAR signaling. Consequently, resistance to many viral pathogens requires
IFNAR as determined by infection of mice deficient in IFNAR (Ifnar1-/-) [3–5] and increased
adverse reactions to attenuated viral vaccines observed in humans with inherited IFNAR defi-
ciency [6].
The discovery of many mechanisms for IFN-I induction was made in fibroblasts [7]. Also,
it is well established that virtually any cell type can produce IFN-I in vitro. However, it is now
apparent that in vivo, the cells that mostly produce IFN-I are myeloid lineage, such as conven-
tional dendritic cells (cDC), plasmacytoid dendritic cells (pDC), or Ly6Chigh inflammatory
monocytes (iMOs) [8]. Similarly, most cell types express IFNAR, and when exposed to IFN-I
in vitro, upregulate ISGs and become more resistant to viral infection [2]. Therefore, the gen-
eral thought is that the stimulation of IFNAR by IFN-I is protective as it can induce ISGs and
the antiviral state in virtually any cell, and because it activates multiple innate and adaptive
immune cell types [9]. However, whether this is true in vivo has not been thoroughly studied.
Ectromelia virus (ECTV) is the etiologic agent of mousepox, which causes fulminant hepa-
titis in mice and resembles human smallpox. C57BL/6 (B6) mice are naturally resistant to
lethal mousepox, and this resistance requires IFN-I, which in the draining lymph node (dLN)
is mostly produced by infected iMOs recruited by dendritic cells (DCs) [10,11]. Defects in the
IFN-I response in vivo such as the absence of IFNAR [12,13], the DNA sensor Cyclic
GMP-AMP synthase (cGAS) [14,15], the signaling adapter Stimulator of Interferon Genes
(STING) or the transcription factor Interferon regulatory factor 7 (IRF7) [11], results in
unchecked ECTV replication, impairment of the adaptive immune response, and death.
Given that IFN-I signaling is crucial for mousepox resistance, it is an excellent model to
uncover which cells need to receive IFN-I signaling through IFNAR to resist a lethal viral
infection, and to determine whether hematopoietic and non-hematopoietic cells require
intrinsic IFNAR. This question is especially intriguing in the context of hepatocytes, which are
non-hematopoietic and a key target of ECTV pathogenesis. Furthermore, considering that
resistance to mousepox needs a robust cytotoxic response by both innate Natural Killer (NK)
and adaptive T cells, it is important to investigate whether resistance to viral disease requires
intrinsic IFNAR in these cell types. Also, given the critical role of iMOs in IFN-I production, it
is of interest to define the role of IFNAR in these cells.
Results
IFNAR in hematopoietic cells is necessary and sufficient for resistance to
lethal mousepox
To test whether hematopoietic or non-hematopoietic cells require IFNAR signaling for resis-
tance to mousepox, we lethally irradiated B6 and Ifnar1-/- mice and reconstituted them with
either B6 or Ifnar1-/- bone marrow cells to generate B6! B6, Ifnar1-/-! B6, B6! Ifnar1-/- and
Ifnar1-/-! Ifnar1-/- bone marrow chimeras (BMC). Following ECTV infection in the footpad,
all Ifnar1-/-! B6 and Ifnar1-/-! Ifnar1-/- mice succumbed rapidly to the infection, whereas
most B6! Ifnar1-/- and B6! B6 mice survived (Fig 1A). IFNAR deficiency restricted to radio-
resistant cells resulted in only mild susceptibility to mousepox, given that ~70% of B6!
PLOS PATHOGENS Type I interferon receptor in resistance to lethal ectromelia virus infection
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1009593 May 20, 2021 2 / 25
Funding: This work was supported by grants to: 1)
LJS, from the National Institute of Allergy and
Infectious Diseases (https://www.niaid.nih.gov)
R01AI110457, R01AI065544, and T32AI34646,
which supported the salaries of BM and CJK; from
the National Institute on Aging (https://www.nia.
nih.gov) R01AG048602; and from the American
Association of Immunologists ( https://www.aai.
org), Careers in Immunology Fellowship, which
partly supported the salary of CRM). 2) EW, the
National Institute of Allergy and Infectious Diseases
(https://www.niaid.nih.gov) F32AI134646), 3)
Sidney Kimmel Cancer Center at Thomas Jefferson
University, the National Cancer Institute (https://
www.cancer.gov) P30CA056036, for the use of
Flow Cytometry and Laboratory Animal Facilities.
The funders had no role in study design, data
collection and analysis, decision to publish, or
preparation of the manuscript.
Competing interests: No. The authors have
declared that no competing interests exist.
Ifnar1-/- mice survived. The finding that most B6! Ifnar1-/- mice were resistant to mousepox
was surprising because the radioresistant cell compartment includes hepatocytes, which are an
important target of ECTV [16], and epidermal Langerhans cells (LCs), which are required for
optimal innate immune responses to ECTV in the draining lymph node (dLN) and resistance
to mousepox [17]. Thus, we also tested whether the surviving B6! Ifnar1-/- mice had a viral
Fig 1. IFNAR in hematopoietic cells is necessary and sufficient for resistance to lethal mousepox. (A) Survival of the indicated BMCs infected
with 3000 pfu of ECTV-GFP in the footpad. Data were pooled from two independent experiments (Log-rank Mantel-Cox compared to B6! B6
control group). (B) ECTV titers in livers of survivors at endpoint (30 dpi) quantified by plaque assay. The dashed line indicates the detection limit.
Positive control: liver sample harvested from infected Ifnar1-/- mice at 5 dpi. (C-D) ECTV titers in the livers and spleens of each BMC group were
quantified by plaque assay at 5 (C) and 7 dpi (D). The dashed line indicates the detection limit. (E) Number of live splenocytes in BMCs naïve or at
5 and 7 dpi with ECTV. Data are represented as mean ± SEM from three pooled independent experiments (N = 11 per group, multiple comparison
ANOVA with Tukey correction). (F) Isg15 transcripts in the spleen at 5 dpi quantified by qPCR, normalized to Gapdh, and adjusted to fold-change
to naïve. Data are represented as mean ± SEM from two independent experiments (N = 6 per group, multiple comparison ANOVA with Tukey
correction). (G-H) Cre-driven excision of Ifnar1 gene exon10 in the livers (G) and the spleens (H) of the indicated naïve mice measured by qPCR,
normalized by Gapdh transcription, and adjusted to fold-change to B6. (I) Survival of the indicated mice infected as in (A). Data pooled from two
independent experiments (Log-rank Mantel-Cox compared to Ifnar1fl/fl mice). (J-K) ECTV titers in the livers and spleens of indicated mice at 5 (J)
and 7 dpi (K) quantified as in (C-D). Data are represented as mean ± SEM from two or three pooled independent experiments (N = 8–9 for each
Cre+ mice and N = 12–18 for Ifnar1fl/fl mice, ANOVA with Tukey correction compared to Ifnar1fl/fl mice).
https://doi.org/10.1371/journal.ppat.1009593.g001
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clearance defect. However, similar to B6! B6 mice, B6! Ifnar1-/- survivors had no detectable
ECTV in the liver at 30 days post-infection (dpi) (Fig 1B).
We also found that compared to B6! B6 and B6! Ifnar1-/- mice, the viral loads in
Ifnar1-/-! B6 and Ifnar1-/-! Ifnar1-/- mice were increased 10-fold at 5 days post-infection
(dpi) in the spleen (Fig 1C) and 100-fold in the liver and the spleen at 7 dpi (Fig 1D). The
uncontrolled viral replication observed in Ifnar1-/-! B6 and Ifnar1-/-! Ifnar1-/- mice corre-
lated with high pathogenicity in the spleen with a 50 to 100-fold reduction in the number of
splenocytes at 7 dpi when compared to B6! B6 and B6! Ifnar1-/- mice (Fig 1E). The pres-
ence of IFNAR in the hematopoietic compartment was critical for the induction of ISGs
because at 5 dpi Isg15 mRNA, as a readout for IFN-I activity, increased to similar levels in the
spleens of B6! B6 and B6! Ifnar1-/- mice, whereas there was marginal or no Isg15 upregula-
tion in the spleens of Ifnar1-/-! B6 and Ifnar1-/-! Ifnar1-/- mice (Fig 1F) at a timepoint when
numbers of splenocytes were similar among all analyzed groups (Fig 1E). The low upregula-
tion of Isg15 in Ifnar1-/-! B6 mice also indicates that irradiation successfully eliminated most
IFN-responding cells in the spleens of Ifnar1-/-! B6 mice.
To confirm our findings in another system, we crossed Ifnar1fl/fl mice [18] with mice
expressing Cre recombinase from the Vav1 promoter [19] to delete IFNAR in all hematopoi-
etic cells (Ifnar1ΔVav1 mice) or from the Alb promoter [20] to delete IFNAR exclusively in
hepatocytes (Ifnar1ΔAlb1 mice). The specificity of the deletion was confirmed by quantitative
PCR (qPCR) for Ifnar1 transcripts in the liver (Fig 1G) and the spleen (Fig 1H). In agreement
with the experiments with BMC, all infected Ifnar1ΔVav1 mice succumbed rapidly to infection
while most Ifnar1ΔAlb1 and Ifnar1fl/fl littermates survived (Fig 1I). Moreover, when compared
to Ifnar1fl/fl littermates, Ifnar1ΔVav1 but not Ifnar1ΔAlb1 mice had a significant increase in viral
loads in the livers and spleens at 5 (Fig 1J) and 7 dpi (Fig 1K). Based on these results, we con-
clude that IFNAR in hematopoietic cells is essential and generally sufficient for ECTV control
and resistance to lethal mousepox, but is mostly dispensable in hepatocytes, which are critical
targets of ECTV.
IFNAR in hematopoietic cells is necessary for efficient T cell responses to
ECTV
Resistance to mousepox requires functional T and B cells [21–25]. Thus, we analyzed the T cell
responses in B6/Ifnar1-/- BMC. Notably, Ifnar1-/-! B6 and Ifnar1-/-! Ifnar1-/- had a signifi-
cant reduction in the frequency (>10 fold) and absolute numbers (100- to 1000-fold) of CD8
and CD4 T cells expressing granzyme B (GzmB), a marker of activation and cytotoxic potential
(Fig 2A and 2B), and CD44, a marker of antigen-experienced T cells (Fig 2A and 2C) when
compared to B6! B6 mice. In contrast, in B6! Ifnar1-/- mice, the CD8 T cell responses were
not significantly affected, and those of CD4 T cells were significantly but only slightly reduced.
This indicates that IFNAR in hematopoietic cells is necessary for efficient T cell responses to
ECTV.
Intrinsic IFNAR on adaptive lymphocytes is dispensable for efficient T cell
responses and resistance to mousepox
The data above indicated that IFNAR is required in hematopoietic cells for T cell responses to
ECTV but did not indicate whether this requirement is intrinsic or extrinsic for T cells. To test
for these possibilities, we adoptively transferred CFSE-labeled WT F1 (B6.CD45.1 x B6.
CD45.2) and Ifnar1-/- (CD45.2) cells into IFNAR-sufficient mice (B6.CD45.1). Subsequently,
we infected them with ECTV in the footpad and harvested their spleens at 8 dpi (Fig 3A). In
this context, where the host efficiently controls virus replication and spread, Ifnar1-/- and WT
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CD8 and CD4 T cells responded similarly to the infection as determined by CFSE dilution
(Fig 3B and 3C). The frequencies of cells expressing CD44 or GzmB (Fig 3D and 3E), and the
expansion of CD8 T cells specific for the poxvirus immunodominant Kb-restricted epitope
TSYKFESV [26] were also similar (Fig 3D and 3F).
The experiments above indicated that IFNAR deficient T cells could expand and become
effectors in response to ECTV but did not address whether they can protect from mousepox.
To address this issue, we irradiated Rag1-/- mice, which lack T and B cells, and reconstituted
them with: 1) Bone marrow cells from Ifnar1-/- mice (Ifnar1-/-! Rag1-/-) where all hematopoi-
etic cells lacked IFNAR. 2) A mixture of 80% Rag1-/- and 20% Ifnar1-/- bone marrow cells
(Rag1-/- + Ifnar1-/-! Rag1-/- mice) [27], where T cells and B cells lacked IFNAR while most
other hematopoietic cells were IFNAR sufficient. 3) 80% Rag1-/- and 20% B6 bone marrow
cells (Rag1-/- + B6! Rag1-/-) where all hematopoietic cells were IFNAR sufficient. After chal-
lenge with ECTV, all Ifnar1-/-! Rag1-/- mice quickly succumbed to infection whereas similar
to Rag1-/- + B6! Rag1-/-, most Rag1-/- + Ifnar1-/-! Rag1-/- mice survived the infection (Fig
3G) with mild or no signs of disease. Also, at 30 dpi, they had cleared the virus (Fig 3H). Nota-
bly, at 22 dpi, surviving Rag1-/- + Ifnar1-/-! Rag1-/- and Rag1-/- + B6! Rag1-/- mice had simi-
lar frequencies of antigen-experienced CD44+ CD8 and CD4 cells and ECTV-specific Kb-
TSYKFESV+ CD8 T cells in their blood (Fig 3I–3K). Together, these data demonstrate that
intrinsic type I IFN stimulation is not necessary for protective T cell responses to mousepox
and that the lack of T cell responses observed in Ifnar1-/-! B6 and Ifnar1-/-! Ifnar1-/- mice is
T cell extrinsic.
IFNAR on NK cells is essential for resistance to mousepox
Resistance to mousepox requires NK cell cytolytic activity [28–31]. To test whether NK cell
antiviral function requires intrinsic IFNAR, we crossed mice expressing Cre as a knock-in in
the Ncr1 locus (NKp46Cre) with Ifnar1fl/fl mice to generate Ifnar1ΔNKp46 mice, which directs
Fig 2. IFNAR in hematopoietic cells is necessary for efficient T cell responses to ECTV. BMC mice were infected as in Fig 1A, and spleens were
harvested at 7 dpi. (A) Representative flow cytometry plots showing the frequency of CD44+ and GzmB+ cells on gated CD8 T cells
(NK1.1-TCRβ+CD8+) and on CD4 T cells (NK1.1-TCRβ+CD4+). (B) Percentages and numbers of cytotoxic GzmB+ CD8 and CD4 T cells. (C)
Percentages and numbers of antigen experienced CD44+ CD8 and CD4 T cells. Data are represented as mean ± SEM from three pooled independent
experiments (N = 11 per group, N = 3 for Ifnar1-/-! Ifnar1-/-, multiple comparison ANOVA with Tukey correction).
https://doi.org/10.1371/journal.ppat.1009593.g002
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Cre to NK cells and other group 1 innate lymphoid cells (ILCs). By flow cytometry, anti-
IFNAR1 monoclonal antibody (mAb) stained T cells and NK cells in Ifnar1fl/fl mice, T cells but
not NK cells in Ifnar1ΔNKp46 mice, and neither T cells nor NK cells in Ifnar1ΔVav1 mice (Fig
4A), demonstrating the NK cell-specific and widespread deficiency of IFNAR1 in Ifnar1ΔNKp46
and Ifnar1ΔVav1 mice, respectively. After ECTV infection, most Ifnar1ΔNKp46 mice succumbed
to mousepox (Fig 4B), with a median survival time of 9.5 days, while most Ifnar1fl/fl littermates
Fig 3. Intrinsic IFNAR on adaptive lymphocytes is dispensable for efficient T cell responses and resistance to mousepox. (A) CFSE-labeled WT (F1
[B6.CD45.1 x B6.CD45.2) and Ifnar1-/- (CD45.2) splenocytes mixed in 1:1 ratio were adoptively transferred i.v. into naïve or infected mousepox resistant
WT hosts (B6.CD45.1), and spleens were harvested at 7.5 days following ECTV infection and transfer. Created with BioRender.com. (B) Representative
flow cytometry histograms of CFSE dilution in gated CD8 T cells (NK1.1-TCRβ+CD8+) in infected and naïve hosts. (C) Percentages of CFSElow CD8 and
CD4 T cells (NK1.1-TCRβ+CD4+). (D) Representative flow cytometry plots showing staining with anti-CD44 and -GzmB (top) or anti-CD44 and Kb-
TSYKFESV dimers (bottom) of donor WT or Ifnar1-/- CD8 T cells. (E) Percentages of CD44+ GzmB+ CD8 and CD4 T cells. (F) Percentages of CD44+ Kb-
TSYKFESV+ CD8 T cells. Data are represented as mean ± SEM from two pooled independent experiments (N = 9 for infected hosts and N = 6 for naïve
hosts). (G) Survival of indicated BMC infected with 3000 pfu of ECTV-GFP in the footpad (Log-rank Mantel-Cox compared to Rag1-/- + Ifnar1-/-! Rag1-/-
and to Rag1-/- + B6! Rag1-/-). (H) ECTV viral titers in the livers of survivors at endpoint (30 dpi) quantified by plaque assay. The dashed line indicates the
detection limit. Positive control: liver sample harvested from infected Ifnar1-/- mice at 5 dpi. (I) Concatenated flow cytometry plots showing levels of Kb-
TSYKFESV+ CD8 T cells and levels of CD44 expression in CD8 and CD4 T cells in the blood of survivor mice at 22 dpi. The graphs of the left are gated on
CD8 T cells. (J) Percentages of CD44+ Kb-TSYKFESV+ CD8 T cells. (K) Percentages of antigen experienced CD44+ CD8 and CD4 T cells. Data are
represented as mean ± SEM from three pooled independent experiments (N = 8 for Rag1-/- + B6! Rag1-/- and N = 11 for Rag1-/- + Ifnar1-/-! Rag1-/-
survivors).
https://doi.org/10.1371/journal.ppat.1009593.g003
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Fig 4. IFNAR on NK cells is essential for resistance to mousepox (A) Concatenated histograms showing IFNAR1 expression in gated NK
(NK1.1+TCRβ-) or T (NK1.1-TCRβ+) cells from spleens of the indicated infected (6 dpi) mice or of Ifnar1fl/fl naïve mice. Concatenated histograms are
derived from one independent experiment (N = 3 or four mice for each group). (B) Survival of the indicated mice infected with 3000 pfu of ECTV-GFP
in the footpad. Data pooled from two independent experiments (Log-rank Mantel-Cox compared to Ifnar1fl/fl mice). (C-D) ECTV titers the livers and
spleens of the indicated mice were quantified by plaque assay at six (C) and eight dpi (D). The dashed line indicates the detection limit. (E-G) Number
of live splenocytes (E), frequency of NK cells (F) and numbers of NK cells (G) in the spleens of naïve and indicated infected mice at 6 and 8 dpi. (H)
Concatenated flow cytometry plots showing NK and T cells gating and CD44 expression, Kb-TSYKFESV-specific and GzmB expression in CD8 T cells
from spleens of Ifnar1fl/fl naïve mice and indicated infected mice at 8 dpi. (I-K) Number of antigen experience CD44+ (I), of CD44+ Kb-TSYKFESV+ (J)
and of CD44+ GzmB+ (K) CD8 T cells in the indicated mice at 8 dpi. Data are represented as mean ± SEM from two pooled independent experiments
(N = 9 or 10 for each group, ANOVA with Tukey correction compared to Ifnar1fl/fl infected mice).
https://doi.org/10.1371/journal.ppat.1009593.g004
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survived, indicating that intrinsic IFNAR signaling in NK cells is vital for optimal resistance to
mousepox.
To understand how the lack of intrinsic IFNAR signaling in NK cells predisposes mice to
ECTV lethality, Ifnar1ΔNKp46, Ifnar1ΔVav1, and Ifnar1fl/fl mice were infected with ECTV and ana-
lyzed at 6 and 8 dpi. Viral loads in the liver and spleen of Ifnar1ΔNKp46 and Ifnar1fl/fl mice were
similar and significantly lower than in Ifnar1ΔVav1 mice, suggesting that during the first 6 dpi,
intrinsic IFNAR signaling in NK cells may not be essential to control ECTV but could be neces-
sary in other hematopoietic cells (Fig 4C). The NK cells’ intrinsic IFNAR defect resulted in
increased viral loads in the spleen and the liver at 8 dpi (Fig 4D). Compared to infected Ifnar1fl/fl
mice, the numbers of splenocytes were significantly reduced in ECTV-infected Ifnar1ΔVav1 but
not in Ifnar1ΔNKp46 at 6 dpi, but at day 8 dpi, Ifnar1ΔNKp46 had reduced numbers of live spleno-
cytes compared to Ifnar1fl/fl mice (Fig 4E). Notably, at 6 dpi, the frequency and absolute numbers
of NK cells were significantly lower in the spleens of Ifnar1ΔVav1 compared to Ifnar1ΔNKp46 and
Ifnar1fl/fl mice, while at 8 but not 6 dpi, there were significant decreases in the frequency and
numbers of NK cells in Ifnar1ΔNKp46 mice compared to Ifnar1fl/fl mice (Fig 4F and 4G).
Considering that the mean time to death in Ifnar1ΔNKp46 mice infected with ECTV was 9.5
days, we analyzed the T cell response at 8 dpi in the spleens of these mice as a sign of pathoge-
nicity. We found that the frequencies of antigen-experienced (CD44+), ECTV-specific CD8
(CD44+Kb- TSYKFESV) and activated cytotoxic CD8 and CD4 (CD44+GzmB+) T cells were
similar for Ifnar1ΔNKp46 and Ifnar1fl/fl mice (Fig 4H), suggesting that, as expected, IFNAR defi-
ciency in NK cells does not directly compromise T cell activation in vivo. However, given the
reduced numbers of live splenocytes in ECTV-infected Ifnar1ΔNKp46 mice at 8 dpi, the total
number of antigen-experienced CD8 T cells (Fig 4I), of TSYKFESV-specific CD8 (Fig 4J), and
GzmB+ CD8 T cells (Fig 4K) was reduced in Ifnar1ΔNKp46 mice compared to Ifnar1fl/fl mice.
NK cells require IFNAR for optimal maturation, activation, and cytolytic
killing
ECTV-infected Ifnar1fl/fl and Ifnar1ΔNKp46 mice had no differences in frequency of NK cells
that expressed the activation marker CD69, the receptors NKG2D and CD94, which are
required to resist to mousepox [28,29], or the maturation marker KLRG1 [32] (S1A Fig).
There were also no differences in the mean fluorescence intensity (MFI) of NK cells that
expressed the non-classical Major Histocompatibility Class I (MHC-I) molecule Qa-1b, which
has been suggested to increase NK cell survival [33] (S1A Fig). However, we observed higher
frequencies of immature CD27+CD11b- NK cells [34] in Ifnar1ΔNKp46 compared to Ifnar1fl/fl
mice (S1B Fig), suggesting a defect in the ability of NK cells to mature in response to ECTV
infection in the absence of intrinsic IFNAR signaling.
We have previously shown that NK cells upregulate GzmB after infection with ECTV [28].
We now find that different to T cells, the upregulation of GzmB in NK cells in response to
ECTV is partly dependent on intrinsic IFNAR because at 6 dpi a smaller fraction of NK cells
upregulated GzmB in Ifnar1ΔNKp46 compared to Ifnar1fl/fl infected mice (Fig 5A, left). Also,
using a mAb to perforin (Prf), we found that most NK cells produce intermediate levels of Prf
at steady state. At 6 dpi with ECTV, Prf expression was upregulated in NK cells, many of them
to high levels. Notably, most NK cells also upregulated Prf in Ifnar1ΔNKp46 mice, but several
remained at an intermediate stage, similar to naïve Ifnar1fl/fl (Fig 5A, right). Consequently, at
6 dpi, a significantly lower fraction of NK cells was GzmBhigh Prfhigh in Ifnar1ΔNKp46 compared
to Ifnar1fl/fl mice (Fig 5B and 5C).
The previous data suggested a possible defect in NK cell cytolytic function in the absence of
intrinsic IFNAR signaling. TAP1-deficient splenocytes (Tap1-/-) adoptively transferred into
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naïve mice are killed by NK cells due to their low expression of MHC-I at the cell surface
[35,36]. We have previously shown that the preferential killing of Tap1-/- over WT splenocytes
is significantly higher in mice infected with ECTV for 6 days as compared to naïve mice [37].
Notably, we found that NK cells were significantly less effective at killing Tap1-/- cells in vivo in
Ifnar1ΔNKp46 mice than in Ifnar1fl/fl mice following ECTV infection (Fig 5E and 5F). These
results indicate that NK cell intrinsic IFNAR signaling is necessary for optimal NK cell killing
during an acute viral infection and required for host protection and survival.
Intrinsic IFNAR in Lysozyme-expressing myeloid cells is necessary for
resistance to mousepox
The data above demonstrates that intrinsic IFNAR is required in NK cells but not in T cells for


































































































































































Fig 5. NK cells require IFNAR for optimal maturation, activation, and cytolytic killing. (A) Graphs and
concatenated flow cytometry histograms depicting GzmB and Prf expression in gated NK cells (NK1.1+ TCRβ-) from
spleens of the indicated naïve or infected mice at six dpi. (B-C) Concatenated flow cytometry plots (B) and frequency
(C) of GzmB+ Prf+ NK cells (NK1.1+ TCRβ-) in spleens of the indicated mice at 6 dpi. (D) Mice were infected with
3000 pfu of WT ECTV in the footpad and CFSE-labeled WT + Tap1-/- splenocytes at a 1:1 ratio were transferred i.v.
Two hours before organ harvest at 6 dpi. Created with BioRender.com. (E-F) Concatenated flow cytometry plots (E)
and proportions (F) of the preferential killing of Tap1-/- cells (CFSEhigh CD45.2) over WT cells (CFSEhigh B6.CD45.1)
normalized to donor transfer ratio in spleens of the indicated naïve and infected mice at 6 dpi. Data are represented as
mean ± SEM from two pooled independent experiments (N = 6 or 7 for each group, ANOVA with Tukey correction
compared to Ifnar1fl/fl infected mice).
https://doi.org/10.1371/journal.ppat.1009593.g005
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that Ifnar1ΔVav1 succumbed faster to ECTV (����P<0.0001) and suffered much higher virus
loads than Ifnar1ΔNKp46 mice. This observation suggested that in addition to NK cells, other
innate immune cells require intrinsic IFNAR signaling to resist to mousepox.
We have previously shown that iMOs [11] and LCs, but not conventional dendritic cells 1
(cDC1) [17], play vital roles in the development of the innate immune response in the dLN,
which is required to restrain early virus spread and to resist lethal mousepox. However, it was
unlikely that intrinsic IFNAR signaling was required in LCs since they are radioresistant and
B6! Ifnar1-/- mice were resistant to mousepox (Fig 1A). MO, macrophages (Mf), and neutro-
phils express Lysozyme C-2, encoded by the Lyz2 gene (ImmGen ULI RNASeq and ImmGen
MNP OpenSource). Thus, we crossed Ifnar1fl/fl mice with mice expressing Cre from the Lyz2
promoter [38] to generate Ifnar1ΔLyz2 mice. Consistent with previous reports [39,40], flow
cytometric analysis of splenocytes from naïve Ifnar1ΔLyz2 mice showed that IFNAR was par-
tially deleted in cells of the MO/Mf lineage and also in neutrophils but unaffected in T cells, B
cells, NK cells, cDCs, pDCs and eosinophils (Fig 6A). When we subdivided MOs according to
Ly6C expression, we found that most Ly6Chi but not Ly6Cint or Ly6Clow MO lost expression of
IFNAR in Ifnar1ΔLyz2 mice (Fig 6B). We also attempted to determine IFNAR in subpopula-
tions of cells in the dLN of infected mice, but, unfortunately, anti-IFNAR1 mAb failed to stain
any cells in WT or Ifnar1ΔLyz2 mice, probably due to the high concentration of type I IFNs in
the dLN [11] which compete with anti-IFNAR1 (MAR1-5A3) for binding to the extracellular
domain of IFNAR [41].
Strikingly, most Ifnar1ΔLyz2 mice succumbed to ECTV infection with a mean time of death
of 8.5 dpi (Fig 6C), indicating that IFNAR expression in Lyz2+ cells is necessary for optimal
resistance to lethal mousepox. When we compared virus replication between Ifnar1ΔLyz2 and
control Ifnar1fl/fl mice, we found they did not differ in viral loads in the dLN at 1–2 dpi (Fig
6D). At 3 dpi, the virus loads in Ifnar1ΔLyz2 were slightly higher in the dLN (Fig 6D), but
100-fold higher in the spleen (Fig 6E), indicating faster virus spread. At 5 dpi, Ifnar1ΔLyz2 had
increased virus loads in the liver (Fig 6F) and, at 7 dpi, in both liver and spleen (Fig 6G). Con-
sistent with the pathological changes usually observed in mice susceptible to mousepox,
Ifnar1ΔLyz2 mice had significant reductions in the number of splenocytes, and numbers of
CD44+GzmB+ and CD44+ Kb-TSYKFESV+ CD8 T cells in their spleens (Fig 6H–6J). There-
fore, absence of IFNAR in Lyz2+ cells leads to early viral spread from the dLN to target organs,
exacerbates viral replication at later stages of infection, and indirectly affects the strength of
the T cell response. Of note, the phenotype in Ifnar1ΔLyz2 was less intense than in Ifnar1ΔVav1
mice, suggesting that the roles of IFNAR in Lyz2+, NK cells, and possible other innate immune
cells in resistance to mousepox are complementary and additive.
iMOs require intrinsic IFNAR for optimal transcription of IFN-I genes and
for efficient Ly6C and MHC-II expression but not to migrate to dLNs,
produce CXCL9, or resist infection
The data above shows that in Ifnar1ΔLyz2 mice, neutrophils and Ly6C+ MO partially lose
IFNAR expression. We and others have previously shown that depletion of phagocytes, includ-
ing iMOs, render mice susceptible to mousepox [11,21] and that Ly6C+ iMOs play a critical
role in the early innate immune response to ECTV in the dLN, which is essential to control
early virus spread and resistance to mousepox. On the other hand, neutrophil depletion does
not increase susceptibility to ECTV [42]. Furthermore, while Lyz2-cre is known to delete
floxed genes in LCs [43] and we have shown that LCs are also critical for the innate immune
response to ECTV in the dLN [17], LCs are radioresistant and of host origin in B6Ifnar1-/-
mice, which were resistant to mousepox (Fig 1A). Thus, it was unlikely that the reason for the
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Fig 6. Intrinsic IFNAR in Lysozyme-expressing myeloid cells is necessary for resistance to mousepox. (A) Concatenated flow
cytometry plots showing the gating strategy for cDCs (CD19-TCRβ-NK1.1-CD11chighSiglecH-), pDCs
(CD19-TCRβ-NK1.1-CD11c+SiglecH+), eosinophils (CD19-TCRβ-NK1.1-SiglecH-F4-80+SSC-Ahigh), MO
(CD19-TCRβ-NK1.1-SiglecH-CD11b+Gr-1+Ly6Clow/high), and neutrophils (CD19-TCRβ-NK1.1-SiglecH-CD11b+Gr-1high) and
concatenated histograms showing IFNAR expression in indicated cell populations from spleens of naïve Ifnar1fl/fl and Ifnar1ΔLyz2 mice.
(B) IFNAR1 expression in Ly6Clow, Ly6Cint, and Ly6Chigh gated MO. Histogram legend as in (A). Representative data from one out of
two independent experiments (N = 6 to 7 for each group). (C) Survival of the indicated mice infected s.c. with 3000 pfu of ECTV-GFP.
Data pooled from two independent experiments (N = 10 for Ifnar1ΔLyz2 mice and N = 18 for Ifnar1fl/fl mice, Log-rank Mantel-Cox
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susceptibility of Ifnar1ΔLyz2 mice to mousepox was the deletion of Ifnar1 in neutrophils or LCs.
Thus, we next focused our attention on iMOs.
We have previously shown that iMOs are recruited to the dLN at 2–4 dpi and have two crit-
ical roles for the control of early systemic virus spread: 1) uninfected iMOs secrete CXCL9,
which promotes NK cell recruitment to the dLN [10] and 2) infected iMOs produce type I
IFNs [11,17]. Thus, we compared the iMOs response in dLN of Ifnar1ΔLyz2 and Ifnar1fl/fl mice
at 2 dpi with ECTV-expressing green fluorescent protein (ECTV-GFP) [28] to distinguish
uninfected (GFP-) and infected (GFP+) cells by flow cytometry. We found that Ifnar1ΔLyz2 and
Ifnar1fl/fl mice did not differ either in the number of iMOs recruited to the dLN (S2A and S2B
Fig), the frequency of infected iMOs (S2A and S2C Fig), the number of uninfected iMOs that
produced CXCL9 (S2A and S2D Fig) or the frequency and number of NK cells recruited to
the dLN by the CXCL9 produced by infected iMOs (S2A and S2E Fig). These findings indicate
that iMOs do not require intrinsic IFNAR to be recruited to the dLN, resist infection, or
recruit NK cells.
Because Ly6C+ MOs did not fully delete IFNAR in Ifnar1ΔLyz2 mice, we analyzed the accu-
mulation of iMOs at 3 dpi in the dLN of B6.CD45.1 + Ifnar1-/-! F1 [B6.CD45.1 x B6.CD45.2]
mixed BMC (S2F Fig). We observed similar frequencies (S2F Fig) and infection rates (S2G
Fig) of WT and Ifnar1-/- iMOs, indicating that IFNAR deficiency does not affect iMOs recruit-
ment from the blood to the dLN. However, Ifnar1-/- iMOs had reduced expression of Ly6C
(S2H Fig), and, after infection, did not upregulate surface expression of Major Histocompati-
bility Class II molecules (MHC-II) (S2I Fig, top). WT but not Ifnar1-/- infected iMOs also
trended to upregulate MHC-I after infection, but the differences were not significant (S2I Fig,
bottom).
Our previous work has shown that ECTV infection induces high levels of IFN-I in the dLN
of Ifnar1-/- mice. However, Ifnar1-/- mice also endure high virus loads, which may affect the
IFN-I response [14]. To test whether intrinsic IFNAR deficiency affects the ability of iMOs to
express IFN-I and replicate virus without possible effects of total virus loads in the dLN, we
infected B6.CD45.1 + Ifnar1-/-! F1 [B6.CD45.1 x B6.CD45.2] mixed BMC with ECTV-GFP
and at 3 dpi, we sorted infected (GFP+) and uninfected (GFP-) WT CD45.1 and Ifnar1-/-
CD45.2 iMOs from dLNs of infected mice (Fig 7A). In this context, WT and Ifnar1-/- iMOs
were exposed to the same viral loads within the dLN, and IFN-I production and viral replica-
tion was only dependent on IFNAR expression. As baseline controls, we used MOs from the
spleens of naïve animals. Using qPCR, we found that compared to naïve MOs, both WT and
Ifnar1-/- infected iMOs upregulated IFN-I genes determined as fold-change over naïve using
primers specific for Ifnb1, Ifna4, and Ifna5 or for conserved sequences among all Ifna genes
except Ifna4 (Ifna non-a4) [7]. However, Ifnar1-/- infected iMOs upregulated the transcription
of IFN-I genes to much lower levels than infected WT iMOs (Fig 7B). This major reduction in
IFN-I gene expression by infected Ifnar1-/- iMOs suggests the existence of a positive feedback
compared to Ifnar1fl/fl mice). (D-E) ECTV titers in the dLN (D) and the spleen (E) were quantified by plaque assay at the indicated dpi.
The dashed line indicates the detection limit. Data are represented as mean ± SEM from two or three pooled independent experiments
(N = 5 to 7 for each Cre+ mice and N = 11 to 24 for Ifnar1fl/fl mice; ANOVA with Tukey correction compared to Ifnar1fl/fl mice). (F-G)
ECTV titers in the liver and spleen were quantified by plaque assay at 5 (F) and 7 dpi (G). The dashed line indicates the detection limit.
Data are represented as mean ± SEM from two pooled independent experiments (N = 8 to 9 for each Cre+ mice and N = 18 for Ifnar1fl/fl
mice, ANOVA with Tukey correction compared to Ifnar1fl/fl mice). (H) Representative flow cytometry plots showing levels of CD44 and
GzmB expression and levels of Kb-TSYKFESV-specific CD8 T cells in the spleens of infected mice. (I) Total cell numbers, and
percentages and total numbers of CD44+ GzmB+ CD8 T cells (NK1.1- TCRβ+CD8+) in spleens of the indicated mice at 7 dpi. (J)
Numbers of CD44+ Kb-TSYKFESV-specific CD8 T cells in the spleens of the indicated mice at 7 dpi. Data are represented as
mean ± SEM from two pooled independent experiments (N = 8 to 9 for each Cre+ mice and N = 18 for Ifnar1fl/fl mice, ANOVA with
Tukey correction compared to Ifnar1fl/fl mice).
https://doi.org/10.1371/journal.ppat.1009593.g006
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loop for in vivo expression of IFN-I which, when impaired, culminates in uncontrolled viral
spread from the dLN to target organs and ultimately in death. Notably, sorted infected WT
and Ifnar1-/- iMOs had similar levels of infection when measured as viral transcripts by qPCR
(Fig 7C) or as infectious particles/cell by plaque assay (Fig 7D). This finding indicates that
intrinsic IFNAR signaling does not inhibit viral replication within infected iMOs. Thus, iMOs
require IFNAR to for optimal IFN-I gene transcription but not to be directly protected from
viral infection.
Discussion
Here we used a lethal acute mouse model of viral infection to show that IFNAR mediates pro-
tection mostly by signaling in hematopoietic cells, as indicated by results obtained with
Ifnar1-/- BMC (Fig 1A) and Cre-LoxP conditional deletions (Fig 1I). The observation that
IFNAR expression in hepatocytes does not play a significant role in resistance was unexpected,
considering that ECTV infects hepatocytes and causes severe hepatitis. In agreement with our
observations, others have shown that compared to WT mice, Ifnar1ΔAlb1 mice have similar lev-
els of inflammation and virus loads, whereas Ifnar1ΔLyz2 mice have increased viral loads in the
liver after intravenous challenge with the closely related poxvirus vaccinia virus [40], suggest-
ing a conserved mechanism for IFNAR protection against poxviruses. We have previously
shown that cGAS, which is required for optimal IFN-I production after ECTV infection, is not
necessary in parenchymal cells (including hepatocytes) for resistance to mousepox. We now
show that resistance to mousepox is also independent of IFNAR in hepatocytes. Whether these
characteristics of hepatocytes is the reason for ECTV tropism to the liver is unknown and










































































































Fig 7. iMOs require intrinsic IFNAR for optimal transcription of IFN-I genes. (A) Mixed BMC B6.CD45.1
+Ifnar1-/-! F1 [B6.CD45.1 x B6.CD45.2] were infected with 3000 pfu of ECTV-GFP in the footpad and at 3 dpi,
uninfected (GFP-) and infected (GFP+) WT and Ifnar1-/- iMOs were sorted from the popliteal dLNs as shown in the
representative flow cytometry plots. Created with BioRender.com. (B) IFN-I transcription quantification was
performed by RT-qPCR using RNA extracted from each sorted population as a template. Transcript levels of Ifnb1,
Ifna4, Ifna5, and all Ifna except Ifna4 (Ifna non-a4) were normalized to Gapdh. (C) Transcript levels of the ECTV
EVM36 gene were quantified as in (B). (D) Indicated sorted populations were lysed, and ECTV loads in the indicated
iMOs populations were quantified by plaque assay. Data are represented as mean ± SEM from two pooled independent
experiments for (B) and (C) and from one independent experiment for (D) (ratio paired Student t-test).
https://doi.org/10.1371/journal.ppat.1009593.g007
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Studies using other viral models have shown that IFNAR expression in both hematopoietic
and non-hematopoietic cells may contribute to virus control [44–46], suggesting that viral tro-
pism and pathogenicity might determine which cells need IFNAR expression for protection.
Notably, it was also previously shown that IFNAR expression in hematopoietic cells is detri-
mental for host recovery from infection with a mouse-adapted strain of SARS-CoV [47]. How-
ever, in this same study, it was also reported that early treatment of susceptible mice with IFN-
β was protective and prevented mice from developing lethal pneumonia, suggesting that the
timing of IFN-I response might be critical and very early for airborne diseases.
Optimal activation of adaptive lymphocytes requires more than one signal. Signal 1 is pro-
vided by the activation of the T or B cell receptor whereas Signal 2 is provided by the activation
of co-stimulatory molecules. It has been demonstrated that intrinsic IFNAR expression is
essential for optimal T cell function in some contexts [18] suggesting that IFN-I provides a
necessary Signal 3 [48]. Accordingly, IFN-I stimulation on T and B cells results in the upregu-
lation of activation markers and cytokine secretion [49,50]. However, we observed that, in
vivo, Ifnar1-/- T and B cells were still capable of protecting the host from a primary ECTV
infection and of promoting viral clearance when innate immune cells were IFNAR sufficient
(Fig 3G and 3H). These findings indicate that T and B cells can exert their full antiviral func-
tion independently of IFNAR stimulation and that during a highly inflammatory viral infec-
tion such as ECTV, Signal 3 may not be required or may be provided by alternative or
redundant mechanisms, such as IL-2, IL-6, IL-12, IL-18 or IFN-γ. In agreement with our
observations, it has been shown that conditional deletion of IFNAR in T cells does not affect
CD8 T cell responses to murine gammaherpesvirus infection [51]. Moreover, using a mixed
BMC approach similar to ours (Fig 3G), it has been shown that the adaptive compartment
does not require IFNAR signaling for tumor rejection, whereas the innate immune compart-
ment does [27]. Here we did not explore whether intrinsic IFNAR on adaptive lymphocytes is
required for the generation of memory CD8 T cells or for protection against secondary infec-
tion. However, others have previously shown that Ifnar1 is not required for resistance to sec-
ondary ECTV infection [12].
NK cell function is essential for mousepox resistance, and we have shown here that optimal
protection by NK cells requires intrinsic IFNAR (Fig 4B). The impaired upregulation of
GzmB that we observed in Ifnar1-/- NK cells (Fig 5A) also occurs during non-lethal infection
with mouse cytomegalovirus [33]. It has been shown that intrinsic IFN-I signaling is necessary
for optimal NK cell responses to influenza virus and vaccinia virus [52,53], but how this affects
virus control was not assessed. Here we observed not only a reduction in GzmB expression but
also a decrease in the NK cell pool that expresses both Prf and GzmB (Fig 5B). The finding
that the preferential killing of Tap1-/- cells in ECTV-infected Ifnar1ΔNKp46 mice was signifi-
cantly reduced (Fig 5E) highlights the importance of the crosstalk among innate immune cells
in the dLN where both iMOs and NK cells migrate to upon infection, and where iMOs express
IFN-I. However, IFNAR in iMOs is not required for iMOs or NK cell accumulation in the
dLN (S2A–S2E Fig).
There were no consistent changes in the expression of various NK cells receptors (S1A Fig),
but there was an increase in the frequency of immature NK cells in the spleen of infected
Ifnar1ΔNKp46 mice (S1B Fig). Whether this arrest in development contributes to the reduction
in NK cell cytotoxicity and decreased resistance to mousepox in Ifnar1ΔNKp46 mice is unclear.
It is interesting to note that different from NK cells, the upregulation of GzmB in CD8 T cells
does not require intrinsic IFNAR (Fig 3E). A possible explanation for this difference is that
adaptive lymphocytes may rely more on antigen-specific signals for GzmB upregulation, while
NK cells, which lack antigen receptors, could be more dependent on direct IFN-I signals.
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The finding that partial IFNAR deletion in the monocytic myeloid lineage and neutrophils
(Fig 6A and 6B) results in a significant increase in susceptibility to lethal mousepox (Fig 6C)
is intriguing given the ubiquitous expression of IFNAR and the relatively low frequency of
myeloid cells in tissues in general. Of note, neutrophil depletion does not increase susceptibil-
ity to mousepox [42], cDCs and pDCs express normal levels of IFNAR in Ifnar1ΔLyz2 mice (Fig
6A), and LCs and Kupffer cells are of host origin in mousepox resistant B6!Ifnar1-/- mice
(Fig 1A) indicating that none of these cell types are the culprits for the increased susceptibility
of Ifnar1ΔLyz2 mice to mousepox.
We have previously shown that infected DCs and iMOs are the primary producers of IFN-I
during ECTV infection [11,17,54]. Here, we have used mixed BMCs where WT and Ifnar1-/-
iMOs were exposed to the same environment during infection to show that IFNAR signaling
in infected iMOs is essential to provide a positive feedback loop for IFN-I expression in vivo
(Fig 7B). A positive feedback loop in IFN-I expression was described before in vitro using
fibroblasts infected with Newcastle disease virus [7]. In that context, virus infection readily
induces the transcription of the Ifnb1 and Ifna4 genes. The resulting IFN-β and IFN-α4 signal
through IFNAR to induce IRF7 expression, which leads to the transcription of non-Ifna4
genes. Moreover, Ifnb1-/- mouse fibroblasts were shown to produce less Ifna genes compared
to WT fibroblasts after Sendai virus infection [55]. It is unclear whether a similar mechanism
also regulates IFN-I production in iMOs in vivo or whether different cell types have different
regulatory mechanisms. Considering that Irf7 and Cgas are both ISG and necessary for resis-
tance to ECTV [11,14], it is possible that the IFNAR-dependent positive feedback loop of
IFN-I might be mediated by the increased expression of these genes. Indeed, mRNA-Seq data
of infected and uninfected WT and Ifnar1-/- iMOs support this hypothesis and also confirm
the IFNAR-dependent positive feedback of IFN-I (manuscript in preparation).
We showed that intrinsic IFNAR signaling does not curb virus transcription (Fig 7C) or
production of infectious virus (Fig 7D) in infected iMOs in vivo as a possible mechanism of
IFN-I protection from mousepox. Based on this finding, we speculate that the major role of
IFN-I signaling in resistance to mousepox is regulating the immune response rather than
directly blocking virus replication inside infected cells.
Our data strongly suggest that NK cells and iMOs exert IFNAR-dependent roles that are
indispensable for resistance to ECTV infection. We propose that iMOs must sense paracrine
or autocrine IFN-I through IFNAR to upregulate IFN-I production, which stimulates NK cells
for optimal killing of infected cells and, possibly, other critical protective functions. Our find-
ings contribute to understanding how innate immunity is orchestrated to control viruses and




All the procedures involving mice were carried out in strict accordance with the recommenda-
tions in the Eighth Edition of the Guide for the Care and Use of Laboratory Animals of the
National Research Council of the National Academies. All experiments were approved by
Thomas Jefferson University’s Institutional Animal Care and Use Committee under protocol
number 01727 "Innate Control of Viral Infections."
Reagents
All reagents used are listed in Box 1.
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Box 1. List of reagents.
REAGENT SOURCE IDENTIFIER
Antibodies
Hybridoma anti-mouse Fc gamma receptor FcRII, clone 2.4G2 ATCC HB-197™
Mouse monoclonal antibody BV785 anti-mouse CD45.1, clone A20 BioLegend Cat# 110743, RRID:
AB_2563379
Rat monoclonal antibody PE anti-mouse IgG1, clone RMG1-1 BioLegend Cat# 406607, RRID:
AB_10551439
Mouse monoclonal antibody PerCP-Cy5.5 anti-mouse CD45.2,
clone 104
BioLegend Cat# 109828, RRID:AB_893350
Mouse monoclonal antibody APC anti-mouse CD45.2, clone 104 BioLegend Cat# 109814, RRID:AB_389211
Mouse monoclonal antibody APC anti-mouse NK 1.1, clone PK136 BioLegend Cat# 108710, RRID:AB_313397
Mouse monoclonal antibody BV605 anti-mouse NK 1.1, clone
PK136
BioLegend Cat# 108753, RRID:
AB_2686977
Armenian hamster monoclonal antibody BV605 anti-mouse TCRβ,
clone H57-597
BioLegend Cat# 109241, RRID:
AB_2629563
Armenian hamster monoclonal antibody BV785 anti-mouse TCRβ,
clone H57-597
BioLegend Cat# 109249, RRID:
AB_2810347
Rat monoclonal antibody BV711 anti-mouse CD8a, clone 53–6.7 BioLegend Cat# 100759, RRID:
AB_2563510
Rat monoclonal antibody PE anti-mouse CD8a, clone 53–6.7 BioLegend Cat# 100708, RRID:AB_312747
Rat monoclonal antibody APC-Cy7 anti-mouse CD4, clone RM4-5 BioLegend Cat# 100526, RRID:AB_312727
Rat monoclonal antibody PE-Cy7 anti-mouse CD4, clone RM4-5 BioLegend Cat# 100528
Rat monoclonal antibody BV785 anti-mouse CD4, clone RM4-5 BioLegend Cat# 100552, RRID:
AB_2563053
Rat monoclonal antibody APC Fire750 anti-mouse CD11b, clone
M1/70
BioLegend Cat# 101261, RRID:
AB_2572121
Rat monoclonal antibody BUV395 anti-mouse CD11b, clone M1/70 BD Biosciences Cat# 565976, RRID:
AB_2721166
Armenian hamster monoclonal antibody PerCP-Cy5.5 anti-mouse
CD27, clone LG.3A10
BioLegend Cat# 124214, RRID:
AB_2275577
Rat monoclonal antibody BUV395 anti-mouse CD44, clone IM7 BD Biosciences Cat# 740215, RRID:
AB_2739963
Mouse monoclonal antibody Pacific Blue anti-granzyme B, clone
GB11
BioLegend Cat# 515408, RRID:
AB_2562196
Mouse monoclonal antibody PE anti-mouse perforin, clone
S16009A
BioLegend Cat# 154306, RRID:
AB_2721639
Rat monoclonal antibody APC anti-mouse NKG2D, clone CX5 eBiosciences Cat# 17-5882-82, RRID:
AB_469464
Armenian Hamster monoclonal antibody PE/Cy7 anti-mouse
CD69, clone H1.2F3
BioLegend Cat# 104511
Mouse monoclonal antibody PE anti-mouse IFNAR1, clone MAR1-
5A3
BioLegend Cat# 127312, RRID:
AB_2248800
Armenian hamster monoclonal antibody PE-Cy7 anti-mouse
CD11c, clone N418
BioLegend Cat# 117318
Syrian hamster IgG PE-Cy7 anti-mouse KLRG1, clone MAFA,
2F1-Ag
BioLegend Cat# 138416
Rat monoclonal antibody PerCP/Cy5.5 anti-mouse I-A/I-E, clone
M5/114.15.2
BioLegend Cat# 107626, RRID:
AB_2191071
Rat monoclonal antibody PE anti-mouse Ly6C, clone HK1.4 BioLegend Cat# 128008, RRID:
AB_1186132
Rat monoclonal antibody APC anti-mouse Ly6C, clone HK1.4 BioLegend Cat# 128016, RRID:
AB_1732076
Armenian hamster monoclonal antibody PE anti-mouse CXCL9,
clone MIG-2F5.5
BioLegend Cat# 515603, RRID:
AB_2245490
(Continued)
PLOS PATHOGENS Type I interferon receptor in resistance to lethal ectromelia virus infection
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1009593 May 20, 2021 16 / 25
Box 1. (Continued)
Rat monoclonal antibody Pacific Blue anti-mouse Ly6C/Ly6G (Gr-
1), clone RB6-8C5
BioLegend Cat# 108430, RRID:AB_893556
Rat monoclonal antibody APC Fire750 anti-mouse Ly6C/Ly6G (Gr-
1), clone RB6-8C5
BioLegend Cat# 108456, RRID:
AB_2616737
Rat monoclonal antibody BV785 anti-mouse CD19, clone 6D5 BioLegend Cat# 115543, RRID:
AB_11218994
Rat monoclonal antibody PE anti-mouse CD94, clone 18d3 eBiosciences Cat# 12-0941-81, RRID:
AB_465783
Mouse monoclonal antibody PE-Cy7 anti-mouse H-2Kb/H-2Db,
clone 28-8-6
BioLegend Cat# 114616
Rat monoclonal antibody FITC anti-mouse Siglec-H, clone 551 BioLegend Cat# 129604, RRID:
AB_1227761
Rat monoclonal antibody anti-mouse CD16/CD32, clone 93 BioLegend Cat#101302
Rat monoclonal antibody BV605 anti-mouse CD19, clone 6D5 BioLegend Cat# 115540, RRID:
AB_2563067
Bacterial and Virus Strains
ECTV Moscow ATCC ATCC VR-1374
ECTV-GFP [28] N/A
Chemicals, Peptides, and Recombinant Proteins
CellTrace™ CFSE Cell Proliferation Kit Thermo Fisher Scientific C34554
DMEM media CORNING 10-013-CV
RPMI media CORNING 10-040-CV
Penicillin Streptomycin Solution, 100x CORNING 30-002-Cl
Fetal Bovine Serum, Heat Inactivated Seradigm 1500–500
GlutaMAX 100x Gibco 35050–061
Hepes 1M CORNING 25-060-Cl
BD Cytofix/Cytoperm™ BD Biosciences 51-2090KZ
Peptide TSYKFESV Genscript
NA/LE mouse anti-mouse Qa-1b, 6A8.6F10.1A6 BD Pharmingen 559827
Dimer Kb—BD™ Dimer X BD Biosciences 550750
Liberase™ Roche 05 401 119 001
RNase-free DNase Set Qiagen 79254
Critical Commercial Assays
cDNA synthesis with High Capacity cDNA Reverse Transcription
Kit
Applied Biosystems™ Thermo Fisher Scientific 4368814
RNeasy1Mini Kit Qiagen 74106
iTaq™ Universal SYBR1 Green PCR Supermix BioRad 172–5124
RNA Clean and Concentrator™-5 Zymo Research R1014
Experimental Models: Cell Lines
Monkey C. aethiops epithelial kidney BS-C-1 cells ATCC CCL-26
Experimental Models: Organisms/Strains
Mouse: C57BL/6NCrl Charles River 027
Mouse: B6.SJL-PtprcaPepcb/BoyCrl Charles River 494
Mouse: C57BL/6 Ifnar1-/- mice Thomas Moran (Mount Sinai School of Medicine, New York,
NY)
Mouse: C57BL/6 Ifnar1fl/fl mice Ulrich Kalinke (Institute for Experimental Infection Research,
Brunswick, Germany)
Mouse: B6.129P2-Lyz2tm1(cre)Ifo/J Jackson Laboratory JAX: 004781
Mouse: B6.Cg-Commd10Tg(Vav1-icre)A2Kio/J Jackson Laboratory JAX: 008610
Mouse: B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn/J Jackson Laboratory JAX: 003574
(Continued)
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Mice
All mice used in experiments were 8 to 12 weeks old or 16 to 18 weeks old for BMC. To make
BMC, we used 4 to 6 weeks old females. For all other experiments, both males and females
were used. No sex differences were observed. C57BL/6NCrl (B6) and B6.SJL-PtprcaPepcb/
BoyCrl (CD45.1) mice were purchased from Charles River directly for experiments or as
breeders. B6 and B6.CD45.1 were bred in-house to generate F1 [B6.CD45.1 x B6.CD45.2] het-
erozygous mice. Ifnar1-/- mice backcrossed to B6 were gifts from Dr. Thomas Moran (Mount
Sinai School of Medicine, New York, NY). Ifnar1fl/fl mice were provided by Dr. John Wherry
(University of Pennsylvania, Philadelphia, PA) by permission from Dr. Ulrich Kalinke (Insti-
tute for Experimental Infection Research, Brunswick, Germany). C57BL/6-Ncr1tm1.1(iCre)
Viv/Orl mice (Nkp46-Cre) were a gift of Dr. E. Vivier (Marseille, France). B6.129S7-Rag1tm1-
Mom/J, B6.129P2-Lyz2tm1(cre)Ifo/J, B6.Cg-Commd10Tg(Vav1-icre)A2Kio/J, B6.Cg-Speer6-ps1Tg(Alb-
cre)21Mgn/J were purchased from the Jackson Laboratory. Colonies were bred at Thomas Jeffer-
son University under specific pathogen-free conditions.
Viruses and infection
ECTV Moscow strain (WT) (ATCC VR-1374) and ECTV-GFP [28] were propagated in tissue
culture, as previously described [13]. Briefly, BS-C-1 cells grown in DMEM media
Box 1. (Continued)
Mouse: B6.129S7-Rag1tm1Mom/J Jackson Laboratory JAX: 002216
Mouse: C57BL/6-Ncr1tm1.1(iCre)Viv/Orl E. Vivier (Marseille, France)
Oligonucleotides
Primer Gapdh forward IDT tgtccgtcgtggatctgac
Primer Gapdh reverse IDT cctgcttcaccaccttcttg
Primer Ifnb1 forward IDT ctggcttccatcatgaacaa
Primer Ifnb1 reverse IDT agagggctgtggtggagaa
Primer Ifna4 forward IDT tcaagccatccttgtgctaa
Primer Ifna4 reverse IDT gtcttttgatgtgaagaggttcaa
Primer Ifna5 forward IDT gccttaaccctcctggtaaaa
Primer Ifna5 reverse IDT tcctgtgggaatccaaagtc
Primer Ifna non-a4 forward IDT ARSYtgtStgatgcaRcaggt
Primer Ifna non-a4 reverse IDT ggWacacagtgatcctgtgg
Primer Isg15 forward IDT agtcgacccagtctctgactct
Primer Isg15 reverse IDT ccccagcatcttcaccttta
Primer EVM36 forward IDT tgccagttagcactgcgtat
Primer EVM36 reverse IDT aggtgttctggagaatcaaaga
Primer Ifnar1 exon 10 forward IDT gctttgaggagcgtctggaa
Primer Ifnar1 exon 10 reverse IDT tcatcaatactgcggggagg
Software and Algorithms
Prism 8 Software GraphPad Software
FlowJo™ version 10 Treestar
Other
TissueLyzer II Qiagen 85300
Thermocycler CFX96 Real-Time System BioRad
BD FORTESSA™ cytometer BD Biosciences
FACSAria™ II sorter BD Biosciences
https://doi.org/10.1371/journal.ppat.1009593.t001
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supplemented with 10% fetal bovine serum (FBS), 100 IU penicillin, 100 μg/mL streptomycin,
1x GlutaMAX, and 10mM HEPES to confluency were infected at MOI 0.01, and viruses were
harvested 4 to 5 days later. For that, cells were rinsed with phosphate-buffered solution (PBS),
scraped and concentrated by centrifugation. ECTV was released by multiple freezing and
thawing cycles. Viruses stocks were sonicated and titrated by plaque assay in BS-C-1 cells.
Mice were infected subcutaneously in the rear footpad with 3000 plaque-forming units (PFU)
of ECTV WT or ECTV-GFP as indicated. For sorting monocytes from dLN, mice were
infected in both rear footpads with 3000 PFU of ECTV-GFP in each footpad. In survival
curves, mice were monitored daily and sacrificed whenever illness resulted in a lack of activity
and unresponsiveness to touch. Euthanasia was performed according to the 2013 edition of
the AVMA Guideline for the Euthanasia of Animals. For virus titer quantification, entire or
portions of spleens and portions of livers were homogenized in supplemented DMEM media
using a TissueLyzer II (Qiagen), and organ titers were determined by plaque assay on BS-C-1
cells as described before [13]. Shortly, BS-C-1 cells at confluency were infected with 10-fold
dilutions of each virus sample for 2 hours at 37˚C. Infected cells were grown in 1% carboxy-
methyl cellulose overlay containing DMEM media supplemented with 2.5% FBS, 100 IU/mL
penicillin, 100 μg/mL streptomycin, 1x GlutaMAX and 10mM HEPES. Virus plaques were
quantified at 5 dpi after staining with 0.2% crystal violet dissolved in 20% methanol.
Bone marrow chimeras
Were prepared as previously described [56]. Briefly, 4- to 6-week-old mice previously treated
for three days with acidified water (pH 2.5) were irradiated with 900 Gy using a GammaCell
40 apparatus (Nordion Inc.). Bone marrow cells were isolated in RPMI media supplemented
with 10% FBS, 100 IU/mL penicillin, and 100 μg/mL streptomycin. Red blood cells were lysed
with 0.84% NH4Cl and cells were filtered and counted. Irradiated mice were reconstituted
intravenously with 5–10 million bone marrow cells from donors. Chimeras were given acidi-
fied water for four weeks and rested for eight weeks after reconstitution.
Flow cytometry and sorting
Flow cytometry was performed as previously described [13]. Briefly, organs were processed
into single-cell suspensions. Spleens were smashed with frosted slides, and cells were washed
with RPMI media supplemented with 10% FBS, 100 IU/mL penicillin, and 100 μg/mL strepto-
mycin. Livers were cut into smaller pieces and smashed using syringe plungers and metal
strainers. White and red blood cells were percoll-enriched, and hepatocytes were discarded.
Red blood cells were lysed with 0.84% NH4Cl, washed in media, and counted for staining.
Cells were incubated for 25 min in the fridge in the presence of ab 2.4G2 (Fc gamma receptor
FcRII, ATCC) and surface antibodies. Kb dimer was loaded with TSYKFESV peptide overnight
at 37˚C and subsequently incubated with PE anti-mouse IgG1 for 1 hour at room temperature.
Kb-TSYKFESV PE IgG1 conjugates were incubated with cells for 1 hour at 4˚C. According to
the manufacturer’s instructions, cells were fixed, permeabilized, and stained for 30 min for
intracellular markers with BD Cytofix/Cytoperm™ kit. Data were acquired with a BD FOR-
TESSA™ cytometer and analyzed with FlowJo™ version 10. For sorting iMOs from dLN, mice
were infected as previously with ECTV-GFP in both rear footpads, and 3 dpi popliteal dLN
were collected from infected mice. Spleens from naïve mice were used for sorting naïve iMOs.
dLN were treated with Liberase TM (1.67 Wünsch units/mL) for 30 min in PBS supplemented
with 10mM Hepes. Single-cell suspensions were prepared with 70μm strainer, and repetitive
washes with PBS supplemented with 2% BSA and 10mM Hepes. Cells were counted, treated
with anti-mouse CD16/CD32 (BioLegend—0.25μL per million of cells) for 15 min in the at
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4˚C in PBS supplemented with 2% BSA and 1mM EDTA and subsequently stained with sur-
face antibodies for 20 min at 4˚C. Cells were washed and sorted with a FACSAria™ II sorter in
PBS supplemented with 1% BSA, 25mM Hepes, and 1mM EDTA.
CFSE labeling and adoptive transfers
Splenocytes from indicated donor mice were isolated in RPMI media supplemented with 10%
FBS, 100 IU/mL penicillin, and 100 μg/mL streptomycin. Red blood cells were lysed with
0.84% NH4Cl. Splenocytes were washed with a pre-warmed phosphate-buffered solution
(PBS) containing 0.1% bovine serum albumin (BSA) and filtered in 70μm sterile nylon mesh.
Cells were adjusted to 50 million cells/ml concentration, and a 1:1 ratio of donor mix was
labeled with 4μM CellTrace™ CFSE Cell Proliferation Kit for 10 min at 37˚C. Recipient mice
were injected intravenously with 0.4 to 2 x 107 of CFSE-labeled cells and infected at indicated
times with ECTV.
RNA preparation and Reverse Transcription-qPCR
Total RNA from spleens and livers was purified with the RNeasy Mini Kit (Qiagen) and treated
with DNase I (Qiagen). RNA quantified using NanoDrop, and 300 ng were used as a template
for cDNA synthesis with High Capacity cDNA Reverse Transcription Kit in a 20μL reaction.
Quantitative PCR (qPCR) was performed as previously described [11,54]. Shortly, 1μL of
cDNA was used as a template for amplification using SYBR Green PCR Master Mix through
92˚C for 3 min, 25 cycles of 92˚C for 30 sec, 56˚C for 45 sec, 65˚C for 50 sec, plate read in a
Thermocycler CFX96 Real-Time System (BioRad). For purifying RNA from sorted popula-
tions, cells were sorted into Trizol, and the RNA was purified with the RNA Clean and Con-
centrator (Zymo Research). RNA was eluted in 10μL, and all RNA was used as a template for
cDNA synthesis. Gene expression was normalized by Gapdh levels.
Quantification and statistical analysis
Data were analyzed with Prism 8 Software. Log-rank (Mantel-Cox) analysis was used for sur-
vival experiments. ANOVA with Tukey correction for multiple comparisons or paired and
unpaired Student’s t-test were used as applicable for other experiments. In all figures, �p<0.05,
��p<0.01, ���p<0.001, ����p<0.0001. Graphs show mean +/- SEM.
Supporting information
S1 Fig. (relate to Fig 5). Deletion of IFNAR1 in NK cells results in increased frequency of
immature NK cells after ECTV. (A-B) The indicated mice were infected with 3000 pfu of
ECTV-GFP in the footpad and spleens were harvested at 6 dpi. (A) Concatenated histograms
and graphs showing proportions of KLRG1, NKG2D, CD69 and CD94 expression in gated
NK cells (NK1.1+ TCRβ-) and MFI of expression of Qa-1b+ NK cells. (B) Concatenated flow
cytometry plots and pie charts showing average proportions of NK cells subpopulations based
on CD27 and CD11b expression. Data are represented as mean from two pooled independent
experiments (N = 6 or 7 for each group, ANOVA with Tukey correction compared to Ifnar1fl/fl
infected mice).
(TIF)
S2 Fig. (related to Fig 7). iMOs require intrinsic IFNAR for efficient Ly6C and MHC-II
expression but not to migrate to dLNs, produce CXCL9, or resist infection. (A-D) Indi-
cated mice were infected with 3000 pfu of ECTV-GFP in the footpad, and at 2 dpi, the popliteal
dLN and collateral non-draining lymph node (ndLN) were harvested. (A) Concatenated flow
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cytometry plots showing proportions of iMOs (CD8-CD4-NK1.1-CD11b+Gr-1+), proportions
of infected (ECTV+), and uninfected (ECTV-) iMOs determined by GFP expression, propor-
tions of CXCL9 expression within ECTV+ and ECTV- iMOs populations, and proportions of
NK cells (CD8-CD4-NK1.1+) observed in the dLN. (B) Numbers of iMOs in dLN. (C) Fre-
quency of infected iMOs expressing GFP in dLN. (D) Numbers of uninfected iMOs expressing
CXCL9. (E) Frequency and numbers of NK cells in dLN. Data are represented as mean ± SEM
from two pooled independent experiments (N = 8–9 for each Cre+ mice and N = 15 for
Ifnar1fl/fl mice, ANOVA with Tukey correction compared to Ifnar1fl/fl mice). (F-I) Mixed
BMCs B6.CD45.1 + Ifnar1-/-! F1 [B6.CD45.1 x B6.CD45.2] were infected with 3000 pfu of
ECTV-GFP in the footpad and the popliteal dLNs were harvested at 3 dpi. (F) Flow cytometry
histograms showing iMOs proportions within WT (B6.CD45.1) and Ifnar1-/- (CD45.2) popu-
lations and histograms depicting levels of Ly6C expression in each of these iMOs populations.
(G) Flow cytometry plots showing ECTV- and ECTV+ iMOs as determined by GFP expression
in WT and Ifnar1-/- iMOs and graph showing the percentages of ECTV+ iMOs. (H) Flow
cytometry histograms showing Ly6C expression in infected and uninfected iMOs and mean
fluorescence intensity of Ly6C+ in ECTV- and ECTV+ iMOs populations. (I) Flow cytometry
histograms showing levels of KbDb MHC-I and MHC-II expression in Ly6C+ ECTV+ iMOs
and mean fluorescence intensity of these molecules in ECTV+ and ECTV- Ly6C+ iMOs. Data
are represented as mean ± SEM from three pooled independent experiments in which dLNs
from individual BMCs (N = 8–10 mice per experiment) were pooled together for flow cytome-
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